Variables | Overall n = 131(%) | Oxalate calcium n = 96 (%) | Phosphates n = 18 (%) | Purines n = 17(%) | p |
---|---|---|---|---|---|
Sex | 0,068 | ||||
Female | 37(28,0) | 29(30,2) | 7(38,9) | 1(5,9) | |
Male | 94(72,0) | 67(69,8) | 11(61,1) | 16(94,1) | |
Age | 0,035 | ||||
< 19 years | 6(4,6) | 4(4,2) | 1(5,6) | 1(5,9) | |
20–39 years | 38(29,0) | 30(31,2) | 8(44,4) | 0(0,0) | |
40–59 years | 48(36,6) | 38(39,6) | 4(22,2) | 6(35,3) | |
≥ 60 years | 39(29,8) | 24(25,0) | 5(27,8) | 10(58,8) | |
Residence | 0,001* | ||||
Kinshasa | 116(88,5) | 88(91,7) | 11(61,1) | 17(100,0) | |
Hors Kinshasa | 15(11,5) | 8(8,3) | 7(38,9) | 0(0,0) | |
Province of origin** | 0,008* | ||||
West | 62(47,3) | 49(51,0) | 5(27,8) | 8(47,1) | |
North | 18(13,7) | 17(17,7) | 1(5,6) | 0(0,0) | |
Center-south | 33(25,2) | 22(22,9) | 5(27,8) | 6(35,3) | |
East | 18(13,7) | 8(8,3) | 7(39,9) | 3(17,6) | |
Urinary tract infection | 0,102* | ||||
Yes | 43(32,8) | 27(28,1) | 5(27,8) | 11(64,7) | |
No | 28(21,4) | 24(25,0) | 2(11,1) | 2(11,8) | |
No specified | 60(45,8) | 45(46,9) | 11(61,1) | 4(23,5) | |
Prostatic adenoma | 0,005* | ||||
Yes | 27(20,4) | 12(33,3) | 3(50,0) | 11(87,6) | |
No | 29(22,0) | 24(66,7) | 3(50,0) | 2(15,4) | |
Female/Child/No specified | 76(57,6) | 60(62,5) | 12(66,7) | 4(22,2) | |
Seat of stones | 0,001 | ||||
Upper urinary tract | 82(62,6) | 70(72,9) | 9(50,0) | 3(17,6) | |
Low urinary tract | 49(37,4) | 26(27,1) | 9(50,0) | 14(82,4) |